Getting To The Heart Of The 40-Year-Long Framingham Study

In 1948, a group of government researchers arrived in a small New England city to begin a long-term epidemiologic study of its residents. In the ensuing 42 years, their research has come to have considerable impact on health care in the United States. The project, the Framingham Heart Study, conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, has provided surveillance of the cardiac health of a randomly selected sample of men and women from

Written byLisa Holland
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The project, the Framingham Heart Study, conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, has provided surveillance of the cardiac health of a randomly selected sample of men and women from Framingham, Mass. (see accompanying story). Its prospective nature has made it possible to define factors that may eventually lead to cardiovascular disease and, as a result, has triggered national health trends geared to intervene and reduce risk.

As the data-collecting phase of the study draws to a close (funding is expected to expire in 1992), a look back over the past several decades reveals a body of valuable information that has had significant impact in cardiovascular disease research.

"The Framingham Heart Study was created to study the incidence of coronary heart disease and the factors related to its development," explains William B. Kannel, former study director and currently professor of medicine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA